https://www.jnj.com/media-center/press-releases/janssen-submits-new-drug-application-to-u-s-fda-seeking-approval-of-investigational-single-tablet-combination-therapy-of-macitentan-and-tadalafil-for-treatment-of-patients-with-pulmonary-arterial-hypertension-pah
This is the first and only single tablet combination therapy application to be submitted for review in the U.S. for this rare, progressive disease If approved,...
new drug applicationjanssensubmitsfdaseeking
https://www.psychiatrictimes.com/view/fda-clears-investigational-new-drug-application-for-tnx-102-sl-for-treatment-of-major-depressive-disorder
Nov 24, 2025 - Psychiatric Times is the connection to Psychiatry and Mental Health, featuring clinical updates, expert views, and research news in multimedia formats.
investigational new drugfdaclearsapplicationtnx
https://www.takeda.com/en-us/newsroom/news-releases/2011/takeda-resubmits-new-drug-applications-in-the-us-for-investigational-type-2-diabetes-therapies-alogliptin-and-the-fixed-dose-combination-alogliptinpioglitazone/
Takeda Resubmits New Drug Applications in the U.S. for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination...
new drug applicationsin thetakeda
https://www.biospace.com/biocity-announces-fda-clearance-of-investigational-new-drug-application-for-its-first-in-class-cd3-egfr-bispecific-antibody
BioCity Biopharma announced that the U.S. Food and Drug Administration has cleared the company's Investigational New Drug application for a Phase 1 study of...
investigational new drugannouncesfdaclearanceapplication